Are Jeevan Scientific Technology Ltd latest results good or bad?

Jeevan Scientific Technology Ltd's latest financial results for Q3 FY26 indicate a notable operational turnaround, as the company returned to profitability with a consolidated net profit of ₹1.42 crores, contrasting with a loss of ₹0.09 crores in the previous quarter. This recovery is underscored by a significant revenue growth of 54.04% quarter-on-quarter and 52.44% year-on-year, reaching a record net sales figure of ₹19.07 crores. The operating profit margin also improved to 27.43%, marking the best performance in four quarters, which suggests enhanced operational efficiency and a favorable project mix. Despite these positive developments, the company continues to face challenges, as it remains loss-making on a trailing twelve-month basis. The average return on equity (ROE) of 9.56% indicates weak capital efficiency, and the latest ROE has turned negative at -9.28%, reflecting the impact of previous losses. The five-year EBIT growth of -204.41% highlights ongoing operational difficulties, raising concerns about the sustainability of the recent improvements. The company's balance sheet shows a modest increase in shareholder funds, but long-term debt has risen, indicating increased leverage. The absence of institutional investors further complicates the outlook, as it suggests a lack of confidence in the company's financial health and governance. Overall, while Jeevan Scientific Technology Ltd's Q3 FY26 results reflect a significant operational improvement with strong revenue and margin growth, the underlying challenges related to profitability consistency and capital efficiency remain critical points for monitoring. The company has experienced an adjustment in its evaluation, reflecting the mixed signals presented by its financial performance.